Skip to main content

Table 2 Comparison of T790M mutation, as detected by ddPCR and ARMS

From: Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study

ARMS

ddPCR

Total

T790M+

T790M−

T790M+

87

8

95

T790M−

58

154

212

Total

145

162

307

  1. ARMS amplification refractory mutation system, ddPCR droplet digital PCR
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us